☆ 4.7 Letter

Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis

ANNALS OF THE RHEUMATIC DISEASES (2021)

Journal

ANNALS OF THE RHEUMATIC DISEASES

Volume 80, Issue 12, Pages 1635-1638

Publisher

BMJ PUBLISHING GROUP

DOI: 10.1136/annrheumdis-2021-220862

Keywords

COVID-19; vaccination; methotrexate; biological therapy; glucocorticoids

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis

Journal

ANNALS OF THE RHEUMATIC DISEASES

Publisher

BMJ PUBLISHING GROUP

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis

Journal

ANNALS OF THE RHEUMATIC DISEASES

Publisher

BMJ PUBLISHING GROUP

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper